Asian Liver Center,
Department of Surgery,
Asian Liver Center, Department of Surgery
Mei-Sze Chua has not added Biography.
If you are Mei-Sze Chua and would like to personalize this page please email our Author Liaison for assistance.
Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons Jan, 2003 | Pubmed ID: 12492705
Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression.
Pediatric transplantation Feb, 2003 | Pubmed ID: 12581329
Microarrays: new tools for transplantation research.
Pediatric nephrology (Berlin, Germany) Apr, 2003 | Pubmed ID: 12700956
Applications of microarrays to renal transplantation: progress and possibilities.
Frontiers in bioscience : a journal and virtual library Sep, 2003 | Pubmed ID: 12957854
Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.
Anticancer research May-Jun, 2006 | Pubmed ID: 16827101
Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Jan, 2007 | Pubmed ID: 17170744
N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells.
Cancer letters Apr, 2008 | Pubmed ID: 18207320
Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo.
Molecular cancer Feb, 2008 | Pubmed ID: 18269767
Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma.
Biomarker insights Jan, 2008 | Pubmed ID: 19578489
Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
International journal of cancer May, 2010 | Pubmed ID: 19662654
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.
Molecular cancer Sep, 2009 | Pubmed ID: 19778454
Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells.
International journal of oncology Dec, 2010 | Pubmed ID: 21042733
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin.
Molecular cancer Feb, 2011 | Pubmed ID: 21314951
Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.
Neoplasia (New York, N.Y.) Aug, 2011 | Pubmed ID: 21847365
Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.
Contrast media & molecular imaging Jul-Aug, 2012 | Pubmed ID: 22649042
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes.
BioMed research international , 2013 | Pubmed ID: 23710458
Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma.
Carcinogenesis Apr, 2014 | Pubmed ID: 24302615
Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.
World journal of gastroenterology Jan, 2014 | Pubmed ID: 24574704
Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.
Biomaterials Aug, 2014 | Pubmed ID: 24836949
Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts.
Oncotarget Jul, 2014 | Pubmed ID: 25051375
Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Oncotarget Sep, 2015 | Pubmed ID: 26246473
NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Oncotarget Oct, 2015 | Pubmed ID: 26359353
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Oncotarget Dec, 2015 | Pubmed ID: 26497681
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Gastroenterology 06, 2017 | Pubmed ID: 28284560
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
Cell research Oct, 2017 | Pubmed ID: 28820176
A transfer-RNA-derived small RNA regulates ribosome biogenesis.
Nature 12, 2017 | Pubmed ID: 29186115
SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Cell death & disease 08, 2019 | Pubmed ID: 31406106
Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Cell death & disease Oct, 2019 | Pubmed ID: 31641102
An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics.
Scientific reports 10, 2019 | Pubmed ID: 31666635
High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.
Cancer management and research , 2019 | Pubmed ID: 31908534
An NIR-II/MR dual modal nanoprobe for liver cancer imaging.
Nanoscale Jun, 2020 | Pubmed ID: 32428058
Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19.
bioRxiv : the preprint server for biology Jun, 2020 | Pubmed ID: 32511305
NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody.
RSC medicinal chemistry Jan, 2022 | Pubmed ID: 35224499
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유